Oncolys, Chugai Ink 50 Billion Yen Licensing Pact for Telomelysin

April 9, 2019
Oncolys Executive Officer Kohei Hata Speaks at Tokyo Press Conference on April 8 Tokyo-based biotech Oncolys BioPharma has won key allies at Chugai Pharmaceutical for the development of its oncolytic virus telomelysin, with the two companies announcing their deal on...read more